Navigation Links
Popular Bone Drugs Linked to Reduced Colon Cancer Risk
Date:2/15/2011

By Steven Reinberg
HealthDay Reporter

TUESDAY, Feb. 15 (HealthDay News) -- People who take drugs called bisphosphonates to prevent bone loss may also reduce their risk of developing colorectal cancer by almost 60 percent compared to those not on the drugs, a new study suggests.

Bisphosphonates include such common drugs as Fosamax (alendronate), Boniva (ibandronate), Actonel (risedronate) and Reclast (zoledronic acid). These drugs work by increasing bone thickness, thereby reducing the risk of fractures, the researchers said.

In prior studies, bisphosphonates have already been shown to be associated with a reduced odds for breast cancer.

"These [new] findings are meaningful because they point to a possible protective effect of this class of drugs being relevant to prevention of many different cancers," said lead researcher Dr. Gad Rennert, from the Technion-Israel Institute of Technology Faculty of Medicine and chairman of the department of community medicine and epidemiology at the Carmel Medical Center of Clalit Health Services in Haifa, Israel.

"This is [similar] to the effect that we and others have shown for [cholesterol-lowering] statins," he said, noting that "bisphosphonates and statins share the same metabolic pathway."

The results of the U.S. National Cancer Institute-supported study are published in the Feb. 14 issue of the Journal of Clinical Oncology.

For the study, Rennert's team collected data on almost 1,900 postmenopausal women who took part in the Molecular Epidemiology of Colorectal Cancer study, which is a population-based trial in northern Israel.

The researchers found that taking bisphosphonates, mostly Fosamax, for at least a year was associated with a significant 59 percent reduction in relative risk for colorectal cancer.

"The magnitude of the reduced risk is less important because this is an association study; however, it is very significant a
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. Bullying May Accompany Drive to Be Popular
2. Zebrafish popular with researchers
3. Tanning Beds Still Popular Despite Skin Cancer Risk
4. Popular Mechanics breakthrough awardees announced
5. Popular prostate cancer treatment associated with bone decay
6. New guideline finds no evidence for a popular back procedure
7. Expert Panel Links Popular Bone Drugs to Rare Fracture
8. Popular diabetes drugs associated with fractures in type 2 diabetic patients
9. New research finds no evidence that popular slimming supplements facilitate weight loss
10. Iceland -- Working on its Popularity for Travellers, Iceland ProTravel Supports Ad Campaign "Inspired by Iceland"
11. SDI Reports: Roughly Half of Patients Prescribed the Most Popular Osteoporosis Drugs Discontinue Therapy Within 6 Months -- Amgen's Prolia Offers New Dosing Option
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Popular Bone Drugs Linked to Reduced Colon Cancer Risk
(Date:6/18/2013)... using technology developed at Case Western Reserve University,s ... of Engineering, has made available avatarsvirtual patientsto train ... and others training to evaluate speech-language disorders to ... on the trainee, because a diagnosis doesn,t have ... , Graduate students studying to become speech-language pathologists ...
(Date:6/18/2013)... IL (PRWEB) June 18, 2013 myCNAjobs ... database of free downloads, articles, and tips to the ... workforce to care for the 10,000+ retiring baby boomers ... and professional caregiver job resources has never ... CNA job community, recently launched the first-ever ...
(Date:6/18/2013)... June 18, 2013 As Mirena lawsuit ... federal court, a new report has revealed that that the ... Food & Drug Administration (FDA) adverse event reports since coming ... Cleveland, Ohio, over 4.700 Mirena users have reported device dislocation ... 1,300 have reportedly experienced uterine perforations due to Mirena.* , ...
(Date:6/18/2013)... the mammary gland appear to provide a crucial link ... and the subsequent development of breast cancer, researchers from ... issue of the journal Cancer Prevention Research . ... with an increased risk of certain types of aggressive ... social stress to cancer have been hard to identify. ...
(Date:6/18/2013)... for the FDA to support the need for a ... States. The University of Rochester Medical Center just added ... Neurotrauma that it might be clinically useful to ... Bazarian, M.D., M.P.H., an associate professor of Emergency Medicine ... measuring a combination of two proteins released into the ...
Breaking Medicine News(10 mins):Health News:SimuCase avatars advance speech-language pathology training 2Health News:myCNAjobs Adds New Resources to Growing Caregiver Career Center 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 2Health News:Mirena Lawsuit News: Bernstein Liebhard LLP Comments on Mounting Reports of Mirena Side Effects, Including Device Migration, Uterine Perforations 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4
... ... for Aesthetic Plastic Surgery indicate breast augmentation has surpassed liposuction after years of dominance ... Dr. Philip J. Straka makes breast surgery procedures a main focus of his practice, ... breast implant studies. , ...
... ... now a featured expert on searchhearthealth.com, a new informational Web site devoted to all aspects ... Potomac, ... clinical nutrition and preventive medicine, is now a featured expert on searchhearthealth.com, a new informational ...
... , , , PITTSBURGH, ... its subsidiary Mylan Pharmaceuticals Inc. has received approval from the U.S. Food and ... Tablets USP, 10 mg and 20 mg. These strengths are in addition to ... of the product. , , Haloperidol Tablets are ...
... financial ties between doctors and drug companies be completely cut, ... common aim of improving human health? A debate in this ... drug company money on doctors is always a corrupting one. ... the subject of intense scrutiny in recent years, with some ...
... ... on healthcare reform with pediatric leaders from [Children,s National Medical Center. , ... Washington, D.C. (Vocus) July ... pediatric leaders from Children,s National Medical Center . The discussion focused on the ...
... , FLEMINGTON, N.J., July 20 A ... of physicians (82%) do not believe that drugs containing acetaminophen should ... (Logo: http://www.newscom.com/cgi-bin/prnh/20071204/NYTU133LOGO ) , , ... MediaCurves.com(R) website during July 17-19, to obtain physicians, perceptions of a ...
Cached Medicine News:Health News:Nation's Most Popular Cosmetic Surgery Procedure is a Way for One Houston Plastic Surgeon to Renew Body Contours and Self-Esteem 2Health News:Nation's Most Popular Cosmetic Surgery Procedure is a Way for One Houston Plastic Surgeon to Renew Body Contours and Self-Esteem 3Health News:Women's Health Expert Dr. Susan Lark Featured on Searchhearthealth.com 2Health News:Can the relationship between doctors and drug companies ever be a healthy one? 2Health News:President Obama Holds Roundtable Discussion on Health Reform at Children's National Medical Center 2Health News:President Obama Holds Roundtable Discussion on Health Reform at Children's National Medical Center 3Health News:President Obama Holds Roundtable Discussion on Health Reform at Children's National Medical Center 4Health News:Docs Say No to Pulling Drugs Containing Acetaminophen off the Market 2Health News:Docs Say No to Pulling Drugs Containing Acetaminophen off the Market 3
(Date:6/17/2013)... 2013 Valeant Pharmaceuticals International, Inc. (NYSE: ... filed a preliminary prospectus supplement to its effective shelf registration ... filing with securities regulatory authorities in each of the provinces ... public offering of its common shares to raise gross proceeds ... will also grant to the underwriters of the Offering an ...
(Date:6/17/2013)... Minn. , June 17, 2013 Prime Therapeutics, ... and design agency, Larsen, was awarded the Silver Anvil for ... Prime Therapeutics." The award was presented at the Public Relations ... held June 13 at the AXA Equitable Center ... The Silver Anvil, which has been presented annually since ...
(Date:6/17/2013)... , June 17, 2013 /PRNewswire-iReach/ -- Weiler Labeling ... new X-4S pressure sensitive labeling head. The X-4S ... and performance requirements that serialization demands. ... is uniquely qualified to work with pharmaceutical and ... serialization and track and trace implementation strategies. Designed ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Public Offering Of Common Shares 2Valeant Pharmaceuticals Announces Public Offering Of Common Shares 3Valeant Pharmaceuticals Announces Public Offering Of Common Shares 4Prime Therapeutics receives prestigious Silver Anvil Award from Public Relations Society of America 2Weiler Labeling Introduces Serialization-Capable X-4S Labeling Head 2
... N.J., Aug. 8, 2011 Systech International®, the recognized ... a leading systems engineering, automation, and manufacturing optimization services ... Agent for the pharmaceutical market in Puerto Rico.  VCG ... for Systech and their extensive customer-base in region. ...
... CORRECTED -- Bionovo, Inc. (NASDAQ: BNVI ) today ... months ended June 30, 2011. "We have ... MF101, or Menerba™, during the past quarter, delivering on milestones ... Executive Officer. "We have completed the tasks which were required ...
Cached Medicine Technology:Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 2Systech Selects Vantage Consulting Group as their Sales Agent in Puerto Rico 3CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 2CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 3CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 4CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results 5
Microforceps with "nail-like" end-gripping platforms; for precise grasping and improved visualization of thin membranes in the macular region....
Blunt tipped forceps with very small grasping platforms on each tip. For grasping very fine membranes or grasping membranes adherent to the retinal surface....
Microforceps: Spaid Pic Forceps...
... As a pioneer in the design ... and extraction of viscous fluids, D.O.R.C. is ... the combination of injection and extraction in ... provides controlled injection of viscous fluids, such ...
Medicine Products: